OVARIAN LOW GRADE SEROUS ADENOCARCINOMA
Clinical trials for OVARIAN LOW GRADE SEROUS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN LOW GRADE SEROUS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN LOW GRADE SEROUS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo targets Hard-to-Treat cancers with RAS mutations
Disease control OngoingThis study tests a combination of two targeted drugs, palbociclib and binimetinib, in people with cancers that have RAS mutations (like certain ovarian and pancreatic cancers). The goal is to see if the combo can slow tumor growth better than one drug alone. About 199 adults will…
Matched conditions: OVARIAN LOW GRADE SEROUS ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 03:23 UTC
-
Can a simple hormone pill replace chemo for some ovarian cancers?
Disease control OngoingThis study tests whether the hormone therapy letrozole alone works as well as chemotherapy plus letrozole for people with stage II to IV low-grade serous ovarian, fallopian tube, or peritoneal cancer. Letrozole lowers estrogen, which can slow tumor growth. The trial aims to find …
Matched conditions: OVARIAN LOW GRADE SEROUS ADENOCARCINOMA
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 11, 2026 20:47 UTC